4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001807359-26-000010
Director sold 17,750 shares at an average $34.38 ($610,252)
- Director acquired 17,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Epperly Melissa B, · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +17,750 | $4.46 | $79,165 | 34,224 | D |
| 2026-06-29 | Sale : show line 2 in the form 10b5-1 | −15,002 | $34.32 | $514,869 | 19,222 | D |
| 2026-06-29 | Sale : show line 3 in the form 10b5-1 | −2,748 | $34.71 | $95,383 | 16,474 | D |
| Open-market sales · 17,750 sh · avg $34.38 · $610,252 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-29 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −17,750 | 169,166 | D |
Loading xslF345X06/wk-form4_1782945259.xml…